NCT02233920View on ClinicalTrials.gov

Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

CompletedOBSERVATIONAL
Enrollment

716

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ventilat® - metered dose inhaler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY